HNB
RCKT icon

Huntington National Bank’s Rocket Pharmaceuticals RCKT Stock Holding History

Huntington National Bank’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-891
Closed -$2.18K – 4189
2025
Q2 		$2.18K Buy
891
+8
+0.9% +$41 ﹤0.01% 2194
2025
Q1 		$5.89K Sell
883
-132
-13% -$1.3K ﹤0.01% 1928
2024
Q4 		$12.8K Buy
1,015
+792
+355% +$11.9K ﹤0.01% 1686
2024
Q3 		$4.12K Sell
223
-5
-2% -$102 ﹤0.01% 2054
2024
Q2 		$4.91K Sell
228
-249
-52% -$5.72K ﹤0.01% 1927
2024
Q1 		$12.8K Buy
477
+19
+4% +$540 ﹤0.01% 1610
2023
Q4 		$13.7K Buy
458
+2
+0.4% +$44 ﹤0.01% 1538
2023
Q3 		$9.34K Sell
456
-24
-5% -$436 ﹤0.01% 1584
2023
Q2 		$9.54K Buy
+480
New +$9.7K ﹤0.01% 1581

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Huntington National Bank's RCKT Position: Q3 2025 in Review

Huntington National Bank sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 891 shares — an estimated $2.18K sold.

Huntington National Bank first reported a position in RCKT in Q2 2023 and held it in 9 quarters. The position peaked at $13.7K in Q4 2023. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Huntington National Bank reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Huntington National Bank sold 891 Rocket Pharmaceuticals shares in Q3 2025, an estimated $2.18K.
  • Huntington National Bank first reported a position in Rocket Pharmaceuticals in Q2 2023 and held it in 9 quarters.
  • Huntington National Bank's Rocket Pharmaceuticals position peaked at $13.7K in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Huntington National Bank's 13F filing for Q3 2025, filed 12 Nov 2025.